How to read: Every bubble is one Indian salmeterol exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Salmeterol report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial salmeterol trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian salmeterol suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Salmeterol India trade report
P
Product scope
Salmeterol
All variants merged — branded and generic formulations of salmeterol
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
316
Every commercial salmeterol trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a steady rise: Oct $90.9K, Nov $492.1K, Dec $1.3M. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$90.9K
Oct USD
16 shipments
2
$492.1K
Nov USD
+441.2% MoM
3
$1.3M
Dec USD
+163.5% MoM
4
Steady rise
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 441.2% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $91K, making it the weakest month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: CIPLA LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import salmeterol from India, how much they buy, and who supplies each market
KEY TAKEAWAYChile absorbs 28.4% of India’s 2025-Q4 salmeterol trade ($533.8K). Beyond the top 10 destinations, 27 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 12 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 27 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much salmeterol India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$622K
33.1% of trade
12 countries · 238 shipments
Europe
$337K
18.0% of trade
5 countries · 23 shipments
Americas
$585K
31.1% of trade
4 countries · 32 shipments
Africa
$335K
17.8% of trade
5 countries · 21 shipments
Oceania
$311
0.0% of trade
2 countries · 2 shipments
Fig 4.1 Chile is the #1 corridor ($534K) — 28 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian salmeterol it receives (light = low, dark = high). Orange arcs radiate from India to the top 28 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
Chile
$534K
18
CIPLA LTD
$520K
PRIME PHARMACEUTICALS PVT LTD
$14K
—
—
2
South Africa
$278K
3
CIPLA LTD
$278K
—
—
—
—
3
Czech Republic
$242K
9
CIPLA LTD
$242K
—
—
—
—
4
Sri Lanka
$186K
3
CIPLA LTD
$186K
—
—
—
—
5
United Arab Emirates
$166K
216
CIPLA LTD
$151K
DERRIC WOOD
$11K
LAWRENCE WALTER
$3K
6
Philippines
$132K
4
KOPRAN LTD
$49K
SRS PHARMACEUTICALS PVT LTD
$36K
LLOYD LABORATORIES PVT LTD
$32K
7
Indonesia
$93K
1
CIPLA LTD
$93K
—
—
—
—
8
Belgium
$53K
10
CIPLA LTD
$53K
—
—
—
—
9
Zimbabwe
$49K
6
CIPLA LTD
$49K
RUTVA MEDICARE
$617
—
—
10
Brazil
$47K
8
GLENMARK PHARMACEUTICALS LTD
$47K
—
—
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 33.1% of USD — but Chile is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
28.4%
#1 country share
Chile alone
74.8%
Top 5 share
5 of 28 countries
99.5%
Top 15 share
Long tail of 13 countries = 0.5%
HHI 1469
Destination HHI
Competitive spread
28
Countries served
Global pharma reach from India
12
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
31 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYCIPLA LTD ($1.6M, 85.7% share) and GLENMARK PHARMACEUTICALS LTD ($89.4K) together control 90.5% of India’s 2025-Q4 salmeterol trade. The top 5 suppliers hold 96.7%. 31 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian salmeterol suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 CIPLA LTD leads by $1.5M over GLENMARK PHARMACEUTICALS LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: GAIA TRADE PVT is #19 by value but #4 by volume.
Fig 5.2 DERRIC WOOD also leads by shipment count (142) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: GAIA TRADE PVT moves from #4 by volume to #19 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 31 salmeterol suppliers split into strategic segments
KEY TAKEAWAY8 suppliers (25%) generate 98.8% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 CIPLA LTD and GLENMARK PHARMACEUTICALS LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 98.8% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
32 importers across 28 countries — who is buying Indian salmeterol and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 94.9% of total USD. 88% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian salmeterol. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 LABORATORIOS RECALCINE SA is the #1 importer at $520K (27.6%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian salmeterol prices vary by supplier, country and dosage form
KEY TAKEAWAYSalmeterol prices span 615× ($0.031 → $19.25). The coefficient of variation is 0.59. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. CIPLA LTDSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. DERRIC WOODSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. KOPRAN LTDSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. KOMAL EXPORTERSSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Nov 2025
IASO PHARMACEUTI…
United Arab Emirates
Inhaler
1
$35.34
$35.34
Specialty / small-batch
Dec 2025
POLLOMI LIFE SCI…
Switzerland
inhalation powder
15
$364.75
$24.32
Specialty / small-batch
Nov 2025
IASO PHARMACEUTI…
United Arab Emirates
Inhaler
3
$69.76
$23.25
Specialty / small-batch
Dec 2025
POLLOMI LIFE SCI…
Switzerland
inhalation powder
15
$288.72
$19.25
Specialty / small-batch
Dec 2025
GAIA TRADE PVT LTD
United Arab Emirates
multihaler
9
$121.51
$13.50
Specialty / small-batch
Nov 2025
GAIA TRADE PVT LTD
United Arab Emirates
—
6
$70.42
$11.74
Specialty / small-batch
Nov 2025
GAIA TRADE PVT LTD
United Arab Emirates
Inhaler
3
$35.19
$11.73
Specialty / small-batch
Nov 2025
GAIA TRADE PVT LTD
United Arab Emirates
—
1
$11.44
$11.44
Specialty / small-batch
Nov 2025
GAIA TRADE PVT LTD
United Arab Emirates
Inhaler
1
$11.43
$11.43
Specialty / small-batch
Dec 2025
RUTVA MEDICARE
Zimbabwe
—
19
$215.61
$11.35
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
PREMIER ENTERPRISE
United Arab Emirates
Inhaler
1
$0.017
$0.017
Small sample / trial shipment
Dec 2025
DERRIC WOOD
United Arab Emirates
Capsule
12
$0.340
$0.028
Small sample / trial shipment
Dec 2025
DERRIC WOOD
United Arab Emirates
rotacaps
6
$0.170
$0.028
Small sample / trial shipment
Dec 2025
GAIA TRADE PVT LTD
United Arab Emirates
Capsule
2
$0.063
$0.031
Small sample / trial shipment
Dec 2025
LAWRENCE WALTER
United Arab Emirates
Capsule
9
$0.396
$0.044
Small sample / trial shipment
Dec 2025
LAWRENCE WALTER
United Arab Emirates
Capsule
6
$0.264
$0.044
Small sample / trial shipment
Nov 2025
CIPLA LTD
Sri Lanka
Capsule
1.1M
$48K
$0.044
Bulk volume discount
Dec 2025
GLENMARK PHARMAC…
Brazil
Inhaler
3K
$142.21
$0.052
Dec 2025
GLENMARK PHARMAC…
Brazil
Inhaler
3K
$142.27
$0.052
Dec 2025
GLENMARK PHARMAC…
Brazil
Inhaler
3K
$141.73
$0.052
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship salmeterol, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYSalmeterol leaves India through 12+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), MUMBAI AIR (SAHAR), NASHIK-JANORI AIR) handle 99.6% of total USD. SEA moves 13% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $1.1M — top 12 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYSEA dominates at 13% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$1.2M
61.3% of USD · 13.0% of ships
AIR
$723K
38.4% of USD · 85.8% of ships
ROAD
$2K
0.1% of USD · 0.3% of ships
ICD
$2K
0.1% of USD · 0.9% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → LatAm ($537K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYBelgium is the most concentrated destination (HHI 10000, 1 suppliers). Philippines is the most competitive (HHI 2830).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Belgium (HHI 10,000) is the most concentrated — Philippines (HHI 2,830) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
LABORATORIOS RECALCI…
Chile
CIPLA LTD
$520K
16
CRITICAL
MEDPRO PHARMACEUTICA…
South Africa
CIPLA LTD
$278K
3
HIGH
CONSIGNMENT STOCK OF…
Czech Republic
CIPLA LTD
$242K
9
HIGH
ACINO PHARMACEUTICAL…
United Arab Emirates
CIPLA LTD
$151K
1
HIGH
BREATHE FREE LANKA (…
Sri Lanka
CIPLA LTD
$138K
2
HIGH
PT DANKOS FARMA
Indonesia
CIPLA LTD
$93K
1
MEDIUM
H.ESSERS & ZONEN INT…
Belgium
CIPLA LTD
$53K
10
MEDIUM
PHARMACEUTICALS & CH…
Zimbabwe
CIPLA LTD
$49K
1
MEDIUM
Conclusion: 28 buyers depend on exactly one Indian supplier, representing $1.8M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
EMIRATES POST COMPANY
United Arab Emirates
4
$11K
DERRIC WOOD
MEDIUM
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
Chile
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
South Africa
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Czech Republic
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Sri Lanka
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
United Arab Emirates
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Philippines
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Indonesia
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Belgium
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Zimbabwe
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Brazil
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Germany
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Malaysia
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Mauritius
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Oman
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Guyana
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 11 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in Chile
This Q
HIGH
A2
Offer alternative to EMIRATES POST
This Q
HIGH
A3
Audit Belgium lock-ins (HHI 10000)
This Q
MED
A5
Enter Zimbabwe (2 suppliers)
This Q
HIGH
A6
Enter Belgium (1 suppliers)
This Q
MED
A8
Build South Africa distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (climbers)
This Q
MED
A7
Register for Chile tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
Zimbabwe
Africa
2
$49K
+310780.7%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
2
Belgium
Other
1
$53K
+34773.9%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
3
Chile
Other
2
$534K
+565.5%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
4
South Africa
Africa
1
$278K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
5
Czech Republic
Other
1
$242K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
6
Sri Lanka
Asia
1
$186K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
7
Philippines
Asia
4
$132K
0%
LOW
Low competition (4 suppliers), accessible market
8
Indonesia
Asia
1
$93K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
9
Brazil
Other
1
$47K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
10
Germany
Other
1
$42K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
11
Malaysia
Asia
1
$33K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Mauritius
Africa
2
$7K
-92.5%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
13
Oman
Other
1
$5K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
14
Guyana
Other
2
$4K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
15
Nepal
Asia
1
$2K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 316 2025-Q4 Salmeterol shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/salmeterol
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 316 2025-Q4 salmeterol shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian salmeterol shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
316
across all regions
TOTAL USD
$1.88M
2025-Q4 FOB value
UNITS
2.8M
tablets, capsules, etc.
SUPPLIERS
31
Indian exporters
BUYERS
32
global importers
COUNTRIES
28
destinations
§10.2 Regional breakdown
Africa
$335K
17.8%
5 ctry · 21 ships
Asia
$622K
33.1%
12 ctry · 238 ships
Europe
$337K
18.0%
5 ctry · 23 ships
Americas
$585K
31.1%
4 ctry · 32 ships
Oceania
$311.40
0.0%
2 ctry · 2 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $335K (17.8%), spanning 5 countries.
🏢
31 Indian suppliers shipped to 32 buyers across 28 countries — average shipment value $6K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 30 global salmeterol importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian salmeterol in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
LABORATORIOS RECALCINE SA
Chile
16
$520K
CIPLA LTD
Inhaler, aerosol inhalation
2
MEDPRO PHARMACEUTICA PTY LTD
South Africa
3
$278K
CIPLA LTD
Inhaler
3
CONSIGNMENT STOCK OF S&D PHARMA CZ
Czech Republic
9
$242K
CIPLA LTD
Inhaler
4
ACINO PHARMACEUTICALS FZ LLC
United Arab Emirates
1
$151K
CIPLA LTD
Inhaler
5
BREATHE FREE LANKA (PVT) LTD
Sri Lanka
2
$138K
CIPLA LTD
Inhaler, Capsule
6
PT DANKOS FARMA
Indonesia
1
$93K
CIPLA LTD
Inhaler
7
H.ESSERS & ZONEN INTERNATIONAL TRAN
Belgium
10
$53K
CIPLA LTD
Inhaler
8
PHARMACEUTICALS & CHEMICAL DIST
Zimbabwe
1
$49K
CIPLA LTD
Inhaler
9
BREATHEFREE LANKA (PVT) LTD
Sri Lanka
1
$48K
CIPLA LTD
Capsule
10
GLENMARK FARMACEUTICA LTDA
Brazil
8
$47K
GLENMARK PHARMACEUTI…
Inhaler, MDI
11
GLENMARK PHARMACEUTICALS S.R.O
Germany
1
$42K
GLENMARK PHARMACEUTI…
Inhaler
12
SRS LIFE SCIENCES INC
Philippines
1
$36K
SRS PHARMACEUTICALS …
13
CIPLA MALAYSIA SDN BHD
Malaysia
6
$33K
CIPLA LTD
Inhaler
14
ZYDUS HEALTHCARE PHILIPPINES INC
Philippines
1
$15K
ZYDUS LIFESCIENCES LTD
Inhaler
15
DROGUERIA INTI S.A
Chile
2
$14K
PRIME PHARMACEUTICAL…
Inhaler
16
EMIRATES POST COMPANY
United Arab Emirates
169
$11K
DERRIC WOOD
Inhaler, rotacaps, Capsule
17
CAPITAL PHARMACY
Oman
1
$5K
CIPLA LTD
Inhaler
18
YETI PHARMACHEM DISTRIBUTORS
Nepal
1
$2K
CIPLA LTD
Inhaler
19
HAROON PHARMA LTD
Afghanistan
1
$2K
CASPIAN PHARMACEUTIC…
Tablet
20
ZAPATERO INTERNATIONAL LTD
Mauritius
1
$2K
PLEASANT EXPORTS
Inhaler
21
ATLAS TRADING COMPANY
Iraq
2
$706.14
VATS INDUSTRIES PVT …
Inhaler
22
LAMPRECHT TRANSPORTS SA
Switzerland
2
$653.47
POLLOMI LIFE SCIENCE…
inhalation powder
23
GOOD HEALTH (PTY) LTD
Seychelles
1
$564.71
JYOTI IMPEX
Inhaler
24
SUCCEED HOLDINGS LTD
Hong Kong
1
$395.45
SANITAS MEDTECH INST…
Inhaler
25
REGENCY EXIM TRADE LTD
Mauritius
4
$352.36
SAVA HEALTHCARE LTD
Inhaler, Capsule
26
EMIRATES POST GROUP
United Arab Emirates
14
$268.33
PREMIER ENTERPRISE
Inhaler
27
KALKAAL HOSPITAL
Somalia
1
$171.00
CURE EARTH PHARMA
inhalation
28
SUCCESS INTER LINK PTE LTD
Singapore
1
$142.66
SANITAS MEDTECH INST…
Capsule
29
PRISM INTERNATIONAL LLC
Seychelles
1
$69.35
MEDMALL PHARMACY PVT…
Other
30
HEALTH CITY CAYMAN ISLANDS (HCCI)
Cayman Islands
2
$2.70
NARAYANA HRUDAYALAYA…
Inhaler
This report covers 316 2025-Q4 Salmeterol shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/salmeterol
Talk to our trade analyst
Need a custom salmeterol report or a deeper dive into any market? Our team is ready.